SYN-TECH CHEM. & PHARM. CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.6 TWD | +2.92% |
|
+3.55% | -0.70% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,354 | 2,492 | 2,321 | 2,616 | 3,755 | 3,799 |
| Enterprise Value (EV) 1 | 2,489 | 2,510 | 2,037 | 2,060 | 3,226 | 3,456 |
| P/E ratio | 15.3 x | 15.6 x | 12.5 x | 19.3 x | 12.7 x | 15.2 x |
| Yield | 4.21% | 4.22% | 5.18% | 3.29% | 3.56% | 4.11% |
| Capitalization / Revenue | 3 x | 2.63 x | 2.36 x | 3.5 x | 3.81 x | 3.41 x |
| EV / Revenue | 3.17 x | 2.65 x | 2.07 x | 2.76 x | 3.27 x | 3.1 x |
| EV / EBITDA | 11.8 x | 9.37 x | 6.16 x | 9.98 x | 10.2 x | 8.85 x |
| EV / FCF | 25.4 x | 10 x | 5.3 x | -6.42 x | -52.2 x | -21.1 x |
| FCF Yield | 3.93% | 9.98% | 18.9% | -15.6% | -1.92% | -4.73% |
| Price to Book | 2.14 x | 2.15 x | 1.87 x | 1.43 x | 1.71 x | 1.64 x |
| Nbr of stocks (in thousands) | 30,060 | 30,060 | 30,060 | 40,060 | 44,592 | 44,592 |
| Reference price 2 | 78.30 | 82.90 | 77.20 | 65.30 | 84.20 | 85.20 |
| Announcement Date | 3/29/19 | 3/30/20 | 3/29/21 | 3/28/22 | 3/22/23 | 3/8/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 784.8 | 946.4 | 983.8 | 746.6 | 986.3 | 1,115 |
| EBITDA 1 | 211.1 | 267.7 | 330.7 | 206.5 | 316.2 | 390.4 |
| EBIT 1 | 149.5 | 200.6 | 262.4 | 146.5 | 238.2 | 281.9 |
| Operating Margin | 19.05% | 21.2% | 26.67% | 19.62% | 24.15% | 25.29% |
| Earnings before Tax (EBT) 1 | 192.1 | 202.9 | 232.9 | 126.9 | 355.2 | 313.8 |
| Net income 1 | 154 | 159.5 | 186.7 | 103.8 | 295.3 | 251 |
| Net margin | 19.62% | 16.85% | 18.98% | 13.91% | 29.94% | 22.52% |
| EPS 2 | 5.120 | 5.300 | 6.200 | 3.380 | 6.610 | 5.620 |
| Free Cash Flow 1 | 97.91 | 250.4 | 384.1 | -321 | -61.8 | -163.5 |
| FCF margin | 12.47% | 26.46% | 39.04% | -42.99% | -6.27% | -14.67% |
| FCF Conversion (EBITDA) | 46.39% | 93.52% | 116.15% | - | - | - |
| FCF Conversion (Net income) | 63.58% | 157.01% | 205.69% | - | - | - |
| Dividend per Share 2 | 3.300 | 3.500 | 4.000 | 2.150 | 3.000 | 3.500 |
| Announcement Date | 3/29/19 | 3/30/20 | 3/29/21 | 3/28/22 | 3/22/23 | 3/8/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 135.5 | 159.5 | 209.1 | 281.8 | 248.1 | 267.3 | 245.1 | 330.4 | 271.9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | - | 7.196 | 13.63 | 55.87 | 84.74 | 61 | 81.12 | 59.02 | 80.06 | 61.65 |
| Operating Margin | - | 5.31% | 8.55% | 26.72% | 30.07% | 24.59% | 30.35% | 24.08% | 24.23% | 22.67% |
| Earnings before Tax (EBT) 1 | - | 1.798 | 42.8 | 86.05 | 141.7 | 29.12 | 81.93 | 84.39 | 115.6 | 31.86 |
| Net income 1 | 28.2 | 1.412 | 34.24 | 68.82 | 113.3 | 23.3 | 65.52 | 67.54 | 92.48 | 25.47 |
| Net margin | - | 1.04% | 21.47% | 32.91% | 40.22% | 9.39% | 24.51% | 27.55% | 27.99% | 9.37% |
| EPS 2 | 0.9400 | 0.0400 | 0.8500 | 1.720 | 2.540 | 0.5200 | 1.470 | 1.510 | 2.070 | 0.5700 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 3/10/22 | 5/9/22 | 8/3/22 | 11/3/22 | 3/22/23 | 5/10/23 | 8/7/23 | 11/6/23 | 3/8/24 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 135 | 17.7 | - | - | - | - |
| Net Cash position 1 | - | - | 284 | 556 | 528 | 343 |
| Leverage (Debt/EBITDA) | 0.6404 x | 0.0662 x | - | - | - | - |
| Free Cash Flow 1 | 97.9 | 250 | 384 | -321 | -61.8 | -164 |
| ROE (net income / shareholders' equity) | 14.7% | 14.1% | 15.6% | 6.76% | 14.1% | 11.1% |
| ROA (Net income/ Total Assets) | 5.53% | 6.8% | 9% | 4.08% | 5.25% | 6.2% |
| Assets 1 | 2,786 | 2,344 | 2,074 | 2,546 | 5,627 | 4,047 |
| Book Value Per Share 2 | 36.60 | 38.60 | 41.30 | 45.70 | 49.30 | 52.00 |
| Cash Flow per Share 2 | 12.70 | 16.10 | 20.60 | 30.70 | 18.90 | 15.00 |
| Capex 1 | 77.2 | 62.8 | 64.5 | 95.5 | 477 | 437 |
| Capex / Sales | 9.84% | 6.63% | 6.56% | 12.79% | 48.4% | 39.23% |
| Announcement Date | 3/29/19 | 3/30/20 | 3/29/21 | 3/28/22 | 3/22/23 | 3/8/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -0.70% | 116M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 1777 Stock
- Financials SYN-TECH Chem. & Pharm. Co., Ltd.
